Does patient sex play a role in treatment-free remission in chronic myeloid leukemia?
- 1 June 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in International Journal of Hematology
- Vol. 111 (6), 903
- https://doi.org/10.1007/s12185-020-02864-3
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trialThe Lancet Haematology, 2020
- Treatment-free remission after first-line dasatinib treatment in patients with chronic myeloid leukemia in the chronic phase: the D-NewS Study of the Kanto CML Study GroupInternational Journal of Hematology, 2020
- Dasatinib discontinuation in patients with chronic-phase chronic myeloid leukemia and stable deep molecular response: the DASFREE studyLeukemia & Lymphoma, 2019